Non-alcoholic Fatty Liver Diseases (NAFLD) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Fatty liver: The sign known to strike in the 'morning' that should not be taken lightly
THE PREVALENCE of non-alcoholic fatty liver disease - the most common liver disease worldwide - is growing at an unprecedented speed. Yet, a great number of NAFLD sufferers are unaware they're affected. One sign when waking up in the morning could be hinting at the disease, recent reports suggest. (Source: Daily Express - Health)
Source: Daily Express - Health - July 12, 2022 Category: Consumer Health News Source Type: news

' Alarming' Global Rise in NAFLD'Alarming' Global Rise in NAFLD
Nearly one third of adults around the world has nonalcoholic fatty liver disease, with cases steadily increasing over the years, and with men more likely than women to have the disease.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 12, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news

PPIs Cleared of Death Risk? 'Alarming' Rise in NAFLD; How IBS Became Hot
(MedPage Today) -- Long-term proton pump inhibitor (PPI) use was not linked to a greater all-cause mortality risk after protopathic bias was accounted for. (Gastroenterology) In a randomized trial, an artificial intelligence-powered smartphone... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 7, 2022 Category: Gastroenterology Source Type: news

Statins in NAFLD: Taking a Closer Look at Benefits Statins in NAFLD: Taking a Closer Look at Benefits
Statins could have multiple benefits in NAFLD, but there has been little insight into how they may be exerting such effects.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 6, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Pemvidutide Promising for Fatty Liver Disease Pemvidutide Promising for Fatty Liver Disease
Weight loss and multiple improvements in lipid parameters linked to nonalcoholic fatty liver disease were seen in a phase 1 trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 1, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom
In main results from the phase 3 trial, as well as those from an open-label extension, the investigational drug also proved its ability to positively influence several noninvasive efficacy outcomes.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 30, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2D
(MedPage Today) -- Notable research presented at the European Association for the Study of the Liver (EASL) annual meeting included studies that showed a sustained response to bulevirtide among patients with difficult-to-treat chronic hepatitis... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - June 29, 2022 Category: Endocrinology Source Type: news

Fatty liver disease: Three signs toxins from the liver have entered the brain
IT IS estimated that one in three adults in the UK are currently living with early-stage fatty liver disease. Also known as non-alcoholic fatty liver disease, it is not linked to how much alcohol you drink. But like its alcohol-related counterpart it can have serious - and potentially fatal - consequences. (Source: Daily Express - Health)
Source: Daily Express - Health - June 28, 2022 Category: Consumer Health News Source Type: news

Mediterranean Diet and Hepatic and Metabolic Outcomes in NAFLD Mediterranean Diet and Hepatic and Metabolic Outcomes in NAFLD
This study compared outcomes of a Mediterranean diet to a low-fat diet in patients with NAFLD. How did they differ in terms of metabolic parameters such as intrahepatic lipids and insulin resistance?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Fatty Liver Disease Drives Rise in Liver Cancer Deaths Fatty Liver Disease Drives Rise in Liver Cancer Deaths
The steep increase in liver cancer deaths is due to the rising rate of NAFLD, rather than alcoholic liver disease or hepatitis B or C, and is mostly driven by the obesity and type 2 diabetes epidemics.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 27, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study Low-Carb, High-Fat Diet Improves A1c, Reduces Liver Fat: Study
A low-carb, high-fat diet reduced NAFLD activity score and HbA1c, and resulted in weight loss, according to a 6-month study of participants with NAFLD and type 2 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 27, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Fatty liver disease symptoms: The signs liver scarring is 'blocking liver function'
LIVER disease comes in two main forms. Non-alcoholic fatty liver disease is the term for a range of conditions caused by a build-up of fat in the liver. You can also get alcohol-related liver disease, which is liver damage that is caused by drinking too much alcohol. The NHS says cirrhosis is "the most severe stage" of NAFLD occurring after years of inflammation. (Source: Daily Express - Health)
Source: Daily Express - Health - June 27, 2022 Category: Consumer Health News Source Type: news

Early Liver Disease Detection Linked to Subsequent Lifestyle Improvements
(MedPage Today) -- Patients at risk for non-alcoholic fatty liver disease (NAFLD) or alcohol-related liver disease (ALD) who underwent liver fibrosis screening subsequently improved their lifestyle, especially those who screened positive, a prospective... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 24, 2022 Category: Gastroenterology Source Type: news

Risk for Existing, Incident T2D High in Children With NAFLD
TUESDAY, June 21, 2022 -- Children with nonalcoholic fatty liver disease (NAFLD) have a high risk for existing and incident type 2 diabetes (T2D), with a prevalence of 16.8 percent, according to a study published online June 13 in Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2022 Category: Pharmaceuticals Source Type: news

Fecal Transplant Durable in IBS; Growth Hormone for NAFLD? Drug Use and DAA Activity
(MedPage Today) -- Fecal microbiota transplant for inflammatory bowel syndrome (IBS) led to high response rates versus placebo and showed durable benefit out to 3 years, a trial from Norway showed. (Gastroenterology) Use of growth hormone in non... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 16, 2022 Category: Gastroenterology Source Type: news